Releases

News

Releases

3. June, 2024

Cessatech announces superior simulated pain efficacy in children

Cessatech announces the final simulated efficacy data in children with CT001 from the abstract...

Read more

Releases

27. May, 2024

Cessatech reports first patient dosed in final Safety Study 0202 of lead product candidate CT001

Cessatech A/S announces that the Safety Study 0202 has now been initiated with dosing...

Read more

Releases

29. February, 2024

Annual Report 2023

Cessatech A/S publishes its annual report for the fiscal year 2023, which also includes...

Read more

Releases

9. January, 2024

Cessatech 2024 major milestones and focus

Now is the time – 2024 will be an extremely busy and hopefully exciting...

Read more

Releases

4. January, 2024

Q&A session – topline data from Study 0205

Link to release: (Link to Q&A session-image)

Read more

Releases

22. December, 2023

Positive topline data from study 0205 with its lead candidate CT001 for the treatment of pain in children supporting further advancement of CT001

The study a double-blinded, randomised, placebo-controlled in adults demonstrated that CT001 was superior to...

Read more

Releases

21. September, 2023

Cessatech announces last participant dosed in pivotal trial 0205 with lead candidate CT001

Last participant has been randomised in clinical trial 0205 investigating efficacy and safety of...

Read more

Releases

12. September, 2023

Cessatech announces agreement with the European Medicines Agency on a Paediatric Investigational Plan for its second asset CT002 for medical procedural sedation in children

On 12 September – Cessatech A/S (“Cessatech” or “the Company”) announces that EMA’s Paediatric...

Read more

Releases

31. August, 2023

August business update

  A short update to the great progress we continue to make….thanks for reading!...

Read more

Releases

24. August, 2023

Second quarter report Q2-2023

US co-development and commercialization partnership signed for CT001 – potential income already from 2024...

Read more

Releases

27. June, 2023

Cessatech and Ventis Pharma announce US partnership for CT001

On 27 June – Cessatech A/S (“Cessatech” or “the Company”) announces that the Company...

Read more

Want to see all releases?

To see all releases including those not listed here, go to our filings and reports.

Stay up to date!

Subscribe and get notified on Cessatech's latest news.
An acceptance email will be sent to you, please check your spam.